Paper · 41597184
Studies of Foxo1 over the Past 25 Years: Mechanisms of Insulin Resistance and Glucose Dysregulation.
Yang W and 3 others. Cells, 2026. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Studies of Foxo1 over the Past 25 Years: Mechanisms of Insulin Resistance and Glucose Dysregulation. Papers, record 41597184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41597184
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Studies of Foxo1 over the Past 25 Years: Mechanisms of Insulin Resistance and Glucose Dysregulation.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Forkhead Box Protein O1 | Major topic |
| Insulin Resistance | Major topic |
| Glucose | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| Energy Metabolism |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01DK120968-19 | NIH HHS | United States | R01DK120968 | PubMed | NIH RePORTER |
| 1R01DK124588-21 | NIH HHS | United States | R01DK124588 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,316,008 | SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15316008 | PubMed |
| 2 | 18,590,693 | Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. | Cell Metab | 2008 | https://conductscience.org/library/papers/18590693 | PubMed |
| 3 | 33,761,350 | FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance. | Cell Rep | 2021 | https://conductscience.org/library/papers/33761350 | PubMed |
| 4 | 23,684,624 | Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. | Cell Metab | 2013 | https://conductscience.org/library/papers/23684624 | PubMed |
| 5 | 32,244,542 | Adipose Tissue and FoxO1: Bridging Physiology and Mechanisms. | Cells | 2020 | https://conductscience.org/library/papers/32244542 | PubMed |
| 6 | 15,879,087 | TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. | J Immunol | 2005 | https://conductscience.org/library/papers/15879087 | PubMed |
| 7 | 29,431,075 | The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells. | Crit Rev Immunol | 2017 | https://conductscience.org/library/papers/29431075 | PubMed |
| 8 | 24,379,407 | Control of Foxo1 gene expression by co-activator P300. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24379407 | PubMed |
| 9 | 37,156,218 | FoxO1 regulates adipose transdifferentiation and iron influx by mediating Tgfβ1 signaling pathway. | Redox Biol | 2023 | https://conductscience.org/library/papers/37156218 | PubMed |
| 10 | 18,978,794 | Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18978794 | PubMed |
1 to 10 of 131
See all 131 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,581,371 | Follicle-stimulating hormone promotes energy metabolism in bovine granulosa cells through the FOXO1-ISG15 pathway to maintain the development of multiple follicles. | J Anim Sci Biotechnol | 2026 | https://conductscience.org/library/papers/42581371 | PubMed |
| 42,199,525 | Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review). | Biomed Rep | 2026 | https://conductscience.org/library/papers/42199525 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FOXO1 | 2,308 | PubTator's text mining | https://conductscience.org/library/genes/2308 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41597184
GET https://conductscience.org/api/papers/v1/41597184/references?page=2